Delivery Order SPE2DB22D9353-SPE2DB26FX1KS
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $9,774.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of FASENRA 30 mg/ml syringes. DMS Pharmaceutical Group Inc. is a critical supplier within the federal pharmaceutical supply chain and has been registered in the System for Award Management since 2001. This delivery order was issued without a set-aside designation, reflecting the...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,330.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of Fasenra 30 mg/ml syringes, and is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999 that runs through December 31, 2025. This IDC, under the SPE2DB program, allows the DLA to issue...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $4,887 firm fixed-price delivery order by the Defense Logistics Agency on September 25, 2025, for Fasenra 30 mg/ml syringes. The contract, which carries an ultimate completion date of September 26, 2025, was issued without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc. under their indefinite delivery contract for pharmaceutical supplies. This $4,887 delivery order is for Fasenra 30 mg/ml syringes to fulfill routine needs at military treatment facilities. As a woman-owned small business, DMS Pharmaceutical Group will provide the specified pharmaceutical item from their facilities in Park Ridge, Illinois by December 12, 2023. Under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,443.50 on July 22, 2025, for the supply of Fasenra 30 mg/mL syringes. The contract, which has no set-aside designation, is set to be completed by July 23, 2025, and will be performed at the vendor's Park Ridge location. This delivery order is funded by the Defense Logistics Agency's Medical Supply Chain division and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $7,330.50 on July 22, 2025, for the supply of Fasenra 30 mg/ml syringes. The contract, with an ultimate completion date of July 23, 2025, was issued without a set-aside designation and funded by the Defense Logistics Agency's Medical Supply Chain division. This delivery order is issued under DMS Pharmaceutical Group's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $14,661.00 to DMS Pharmaceutical Group Inc., a woman-owned small business (WOSB) pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of FASENRA 30 MG/ML SYRINGEML, a specialty pharmaceutical product, with a performance period running through September 5, 2024. This delivery order contract is part of a larger $499,999,999 indefinite delivery contract (IDC) that...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $4,887.00, is for the supply of FASENRA PEN 30 MG/MLML, a pharmaceutical product. This delivery order is under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to $499,999,999 and runs through December 31, 2025. The IDC allows DLA to...
- This firm fixed-price delivery order worth $2,443.50 was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of FASENRA 30 MG/ML SYRINGEML, a specialty medication, with a completion date of September 9, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $19,548.00 by the Defense Logistics Agency on August 26, 2025, for the supply of Fasenra 30 mg/ml syringes. This firm fixed-price delivery order, which is expected to be completed by August 27, 2025, represents a single-line acquisition under the company's existing Indefinite Delivery Contract with DLA. The award carries no set-aside...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB26FX1KSDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $24,435 to DMS Pharmaceutical Group Inc. for Fasenra 30 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The delivery order is scheduled for completion by November 3, 2025, and represents one of numerous pharmaceutical supply orders issued to the contractor by the Defense Logistics Agency's Medical Supply Chain division. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.99 billion ceiling value and extends through December 31, 2036. The PPV-G GEN V is part of a broader $30.3 billion acquisition strategy designed to support recurring medical supply needs of military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across a diverse portfolio of pharmaceutical products—including specialty biologics, oncology treatments, vaccines, and routine medications—positions the company as a critical supplier within the Department of Defense's global healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.4k | 10/31/25 |